Directed Evolution of Next-Generation AAV Vector Systems for Clinical Gene Therapy
Labroots Labroots
33.6K subscribers
9,365 views
0

 Published On Nov 12, 2020

Presented By: David Schaffer


Speaker Biography: David Schaffer is the Hubbard Howe Professor of Chemical and Biomolecular Engineering, Bioengineering, and Neuroscience at the University of California, Berkeley, where he also serves as the Director of the Berkeley Stem Cell Center. He received a B.S. from Stanford University in 1993 and a Ph.D. from MIT in 1998.


Webinar: Directed Evolution of Next-Generation AAV Vector Systems for Clinical Gene Therapy


Webinar Abstract: To gain an understanding of how preclinical and clinical research in gene therapy is leading to strong advances and clinical approvals

To discuss how improvements in delivery technologies, such as engineered AAV delivery vectors, are still needed to fully unlock the potential of gene therapy and genome editing


Earn PACE Credits:
1. Make sure you’re a registered member of LabRoots (https://www.labroots.com)
2. Watch the webinar on YouTube or on the LabRoots Website (https://www.labroots.com/webinar/dire...)
3. Click Here to get your PACE credits (Expiration date – 11/11/2022): (https://www.labroots.com/credit/pace-...)

LabRoots on Social:
Facebook:   / labrootsinc  
Twitter:   / labroots  
LinkedIn:   / labroots  
Instagram:   / labrootsinc  
Pinterest:   / labroots  
SnapChat: labroots_inc

show more

Share/Embed